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World Health Organization statistics
show that deaths worldwide from chronic
noncommunicable diseases (CNCDs) now
exceed those from infectious diseases [1].
The major CNCDs causing the greatest
share of deaths and disability worldwide
include cardiovascular conditions (mainly
heart disease and stroke), some cancers,
chronic respiratory conditions, and type 2
diabetes [2]. Together they account for
60% of all deaths worldwide [2]. Approx-
imately 80% of the CNCD deaths occur in
low-income and middle-income countries
[2]. Most of the factors contributing to
such large numbers of deaths, a large
proportion of which are premature, are
similar to those in developed countries.
They include increasing tobacco use,
diminished physical activity and lack of
exercise, and the consumption of un-
healthy foods [2].
CNCDs are defined as diseases or
conditions that affect individuals over an
extensive period of time and for which
there are no known causative agents that
are transmitted from one affected individ-
ual to another [2]. More than any other
type of infection, the neglected tropical
diseases (NTDs) most closely resemble the
CNCDs. The characteristic feature of the
NTDs are their chronic and insidious
clinical manifestations, and the resulting
long-term disability [3,4]. An impover-
ished person suffering from a NTD will
typically have the condition for years,
sometimes decades, and sometimes their
entire life [3,4]. Indeed, except for the fact
that we know their causative agents, the
NTDs for the most part meet CNCD-
defining criteria. Shown in Table 1 are the
major chronic disease syndromes that
result from NTDs. Chagas disease is a
leading cause of chronic cardiovascular
disease in Latin America, often resulting in
severe cardiomyopathy [5], while Loa loa
and other parasitic infections have been
identified as possible etiologies of endo-
myocardial fibrosis in sub-Saharan Africa
[6]. Urinary schistosomiasis is a leading
cause of bladder cancer in Africa and the
Middle East (causing a unique squamous
cell carcinoma) [7,8], while opisthorchiasis
and clonorchiasis, both causes of oriental
liver fluke infection, cause bile duct carci-
noma in Southeast Asia and China [9].
Worldwide, trichuriasis causes more inflam-
matory bowel disease than either Crohn
disease or ulcerative colitis [10], and
schistosomiasis is a leading cause of chronic
renal disease and failure in Africa and the
Middle East [7,8,11]. In Asia, paragono-
miasis ranks with tuberculosis and lung
cancer as a leading cause of hemoptysis
[12], and toxocariasis is emerging as an
important cause of asthma [13].
Anemia is one of the best documented
examples of a chronic condition in which a
single NTD, such as hookworm infection,
accounts for a significant percentage of the
attributable risk [14–17], or in which
multiple NTD coinfections and polypar-
asitism make a significant contribution
[18–23]. Another is cancer—urinary schis-
tosomiasis was shown to account for 28%
of the bladder cancer in Bulawayo,
Zimbabwe [24], and 0.1% of the world’s
cancer burden [25], while liver flukes (e.g.,
Clonorchis sinensis and Opisthorchis spp.)
account for an estimated 0.02% of all
cancers [25]. Van der Werf et al. deter-
mined that Schistosoma haematobium was
responsible for 10 million cases of hydro-
nephrosis in sub-Saharan Africa, and S.
mansoni was associated with 8.5 million
cases of hepatomegaly in the region [11].
It has been further estimated that approx-
imately 5.4 million people will develop
chronic Chagas heart disease, while
900,000 will develop severe enlargement
of the digestive tract (megacolon and
megaesophagus) [26].
However, the full extent to which the
NTDs listed in Table 1 contribute to the
other CNCDs requires active investiga-
tion. Among the bottom billion living in
the poorest areas of the developing world,
the underlying causes of chronic cardio-
vascular, renal, hepatic, and gastrointesti-
nal disease, as well as cancer, are fre-
quently neglected and unstudied. Because
they are so common in low-income and
middle-income countries, it is of critical
importance to determine how the NTDs
contribute significantly to the CNCD
burden in such regions. Such an evidence
base is critical for informing new policies
for tackling chronic disease in developing
countries. The new Grand Challenges in
CNCDs initiative [2] is an ambitious effort
to raise public awareness of these condi-
tions in the developing world, enhance
economic, legal, and environmental poli-
cies, modify risk factors, mitigate the
health impacts of poverty and urbaniza-
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health systems away from treatment to-
wards prevention [2]. Wherever the NTDs
geographically overlap with the CNCDs,
there is a need to assess the contribution of
the former, and to recognize that when it
comes to NTDs, the distinction between
noncommunicable and communicable dis-
eases can be murky.
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